+612 9045 4394
Immunoconjugate Therapy of Hematologic Malignancies : Environment & Assessment - Steven T. Rosen

Immunoconjugate Therapy of Hematologic Malignancies

Environment & Assessment

By: Steven T. Rosen (Editor), Timothy M. Kuzel (Editor)

Hardcover Published: December 2009
ISBN: 9780792322702
Number Of Pages: 205

Share This Book:


or 4 easy payments of $93.22 with Learn more
Ships in 7 to 10 business days

Other Available Editions (Hide)

  • Paperback View Product Published: 25th September 2012

The hybridoma technique for producing monoclonal antibodies, developed by Drs. Kohler and Millstein in 1975, revolutionized the field of tumor immunology. It is now clear that there are antigens associated with or restricted to human neoplasms that have biologic significance. Monoclonal antibodies have already been demonstrated to have great immunodiagnostic value and it is anticipated that they will become a component of our therapeutic armamentarium. Most investigators in the field, however, feel that the true potential of monoclonal antibodies in cancer therapy remains to be determined. Clearly the most encouraging results have been witnessed in the treatment of hematologic malignancies. This volume of CANCER TREATMENT AND RESEARCH explores the current state of the art of immunoconjugate therapy of hematologic malignancies. Immunoconjugate Therapy of Hematologic Malignancies provides an update of a rapidly advancing field. The preliminary experience of a number of investigators suggests a role for targeted therapy in the treatment of hematologic malignancies. At the present time, immunoconjugates have, in most instances, been reserved for patients with advanced refractory disease. However, it is anticipated in the future that these reagents will be utilized as a complement to traditional therapy or as post-remission consolidation in patients with minimal residual disease. The obstacles have been defined; solutions will require further research and creative imagination.

List of contributors
Radioimmunotherapy of lymphomap. 1
High-dose radioimmunotherapy of lymphomasp. 13
Treatment of leukemia with radiolabeled monoclonal antibodiesp. 23
Imaging and dosimetry determinations using radiolabeled antibodiesp. 65
New approaches to radiolabeling monoclonal antibodiesp. 99
Immunotoxin therapy of lymphomap. 111
Immunotoxins for the therapy for graft versus host diseasep. 133
Recombinant fusion toxins - A new class of targeted biologic therapeuticsp. 145
Chimeric antibodies for the treatment of hematologic malignancyp. 161
Use of bispecific autibodies in the therapy of tumorsp. 181
Indexp. 195
Table of Contents provided by Blackwell. All Rights Reserved.

ISBN: 9780792322702
ISBN-10: 0792322703
Series: Environment & Assessment
Audience: General
Format: Hardcover
Language: English
Number Of Pages: 205
Published: December 2009
Country of Publication: US
Dimensions (cm): 23.39 x 15.6  x 1.42
Weight (kg): 0.49